Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
Top Cited Papers
- 9 October 2002
- Vol. 28 (2) , 158-167
- https://doi.org/10.1016/s1046-2023(02)00220-7
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad SpecificityJournal of Virology, 2002
- Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In VivoJournal of Virology, 2001
- Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene TransferJournal of Virology, 2001
- Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype VectorsMolecular Therapy, 2000
- From the Cover: Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous systemProceedings of the National Academy of Sciences, 2000
- Repeat Transduction in the Mouse Lung by Using Adeno-Associated Virus Vectors with Different SerotypesJournal of Virology, 2000
- The kinetics of rAAV integration in the liverNature Genetics, 1998
- Lack of Site-Specific Integration of the Recombinant Adeno-Associated Virus 2 Genomes in Human CellsHuman Gene Therapy, 1997
- Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA.Proceedings of the National Academy of Sciences, 1994
- Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.Proceedings of the National Academy of Sciences, 1984